j&j featured image
News Pharmaceutical & Biotech Stories

J&J Seeks Emergency Authorization for Single-Shot Vaccines

Pharmaceutical giant Johnson & Johnson submitted its single-shot coronavirus vaccine for emergency use authorization after the vaccine was shown to be robustly effective against COVID-19.

Paul Stoffels, Chief Scientific Officer of Johnson & Johnson, said in a statement, the submission is “a pivotal step toward reducing the burden of disease for people globally and putting an end to the pandemic.”

If the vaccine receives regulatory clearance by the Food and Drug Administration, it would be the third authorized shot in the United States — a much-needed addition to the tools public health officials have to build immunity as virus variants spread.

ASEAN HR TECH VENTURE SUMMIT 2018
REGISTER NOW 33% DISCOUNT
SUMMIT PASS